**7. References**

Audard, V., M. Matignon, et al. (2009). Successful long-term outcome of the first combined heart and kidney transplant in a patient with systemic Al amyloidosis. *Am J Transplant* Vol 9 No (1): 236-240.


Baumgratz, J. F., J. H. Vila, et al. (2009). Heart transplantation in primary amyloidosis. *Rev* 

Bucciarelli-Ducci, C., D. Locca, et al. (2007). Value of cardiovascular magnetic resonance for

Coisne, D., P. Corbi, et al. (2003). Obstructive intramural coronary amyloidosis and papillary

Comenzo, R. L., E. Vosburgh, et al. (1998). Dose-intensive melphalan with blood stem-cell

Conner, R., J. D. Hosenpud, et al. (1988). Heart transplantation for cardiac amyloidosis:

Connors, L. H., A. M. Richardson, et al. (2000). Tabulation of transthyretin (TTR) variants as

Dubrey, S. W., M. M. Burke, et al. (2004). Cardiac transplantation for amyloid heart disease: the United Kingdom experience. *J Heart Lung Transplant* Vol 23 No (10): 1142-1153.

Dubrey, S. W., M. M. Burke, et al. (2001). Long term results of heart transplantation in

Gertz, M. A., R. H. Falk, et al. (1985). Worsening of congestive heart failure in amyloid heart

Gertz, M. A., M. Skinner, et al. (1985). Selective binding of nifedipine to amyloid fibrils. *Am J* 

Gillmore, J. D., L. B. Lovat, et al. (2001). Amyloid load and clinical outcome in AA

Gillmore, J. D., A. J. Stangou, et al. (2001). Clinical and biochemical outcome of hepatorenal

Goffin, Y. (1980). Microscopic amyloid deposits in the heart valves: a common local complication of chronic damage and scarring. *J Clin Pathol* Vol 33 No (3): 262-268. Goldman, B. S. and F. A. Legnami (1966). Senile cardiac amyloidosis: autopsy finding in a

Gorevic, P. D., T. T. Casey, et al. (1985). Beta-2 microglobulin is an amyloidogenic protein in

Griffiths, B. E., P. Hughes, et al. (1982). Cardiac amyloidosis with asymmetrical septal hypertrophy and deterioration after nifedipine. *Thorax* Vol 37 No (9): 711-712. Hall, R. and P. N. Hawkins (1994). Cardiac transplantation for AL amyloidosis. *BMJ* Vol 309

Chamarthi, B., S. W. Dubrey, et al. (1997). Features and prognosis of exertional syncope in

light-chain associated AL cardiac amyloidosis. *Am J Cardiol* Vol 80 No (9): 1242-

disease treated by calcium channel-blocking agents. *Am J Cardiol* Vol 55 No (13 Pt

amyloidosis in relation to circulating concentration of serum amyloid A protein.

transplantation for hereditary systemic amyloidosis associated with apolipoprotein

patient dying after implantation of a cardiac pacemaker. *Can Med Assoc J* Vol 94 No

patients with amyloid heart disease. *Heart* Vol 85 No (2): 202-207.

Cohen, A. S. (1967). Amyloidosis. *N Engl J Med* Vol 277 No (10): 522-530 contd.

responses in 25 patients. *Blood* Vol 91 No (10): 3662-3670.

determining cardiac involvement in systemic amyloidosis. *Eur Heart J* Vol 28 No

support for the treatment of AL (amyloid light-chain) amyloidosis: survival and

successful one-year outcome despite recurrence of the disease. *J Heart Transplant*

*Bras Cir Cardiovasc* Vol 24 No (3): 409-412.

muscle rupture. *Heart* Vol 89 No (2): E8.

of 1/1/2000. *Amyloid* Vol 7 No (1): 54-69.

*Cardiol* Vol 55 No (13 Pt 1): 1646.

*Lancet* Vol 358 No (9275): 24-29.

AI Gly26Arg. *Transplantation* Vol 71 No (7): 986-992.

man. *J Clin Invest* Vol 76 No (6): 2425-2429.

(10): 1186.

1): 1645.

(20): 1055-1058.

No (6962): 1135-1137.

1245.

Vol 7 No (2): 165-167.


Rubinow, A., M. Skinner, et al. (1981). Digoxin sensitivity in amyloid cardiomyopathy.

Saba, N., D. Sutton, et al. (1999). High treatment-related mortality in cardiac amyloid

Shah, K. B., Y. Inoue, et al. (2006). Amyloidosis and the heart: a comprehensive review. *Arch* 

Sharma, P., R. E. Perri, et al. (2003). Outcome of liver transplantation for familial amyloidotic

Schwartz, B. G., J. J. Kuiper, et al. (2007). Combined cardiac and liver transplantation for the

Siqueira-Filho, A. G., C. L. Cunha, et al. (1981). M-mode and two-dimensional

Skinner, M., J. Anderson, et al. (1996). Treatment of 100 patients with primary amyloidosis: a

Tsai, S. B., D. C. Seldin, et al. (2011). Myocardial infarction with "clean coronaries" caused by

Wang, M. M. and J. B. Pollard (2000). Postoperative ventricular fibrillation and undiagnosed

Whitaker, D. C., M. F. Tungekar, et al. (2004). Angina with a normal coronary angiogram

Yagishita, A., S. Tanimoto, et al. (2009). Cardiac amyloidosis presumptively diagnosed as

Zacek, P., K. Medilek, et al. (2007). Cardiac amyloidosis in the cardiosurgical operating room--a rare but fatal trap. *Thorac Cardiovasc Surg* Vol 55 No (2): 65-67.

primary amyloidosis. *Anesthesiology* Vol 92 No (3): 871-872.

caused by amyloidosis. *Heart* Vol 90 No (9): e54.

cardiac syndrome X. *Circ J* Vol 73 No (7): 1349-1351.

patients undergoing autologous stem cell transplant. *Bone Marrow Transplant* Vol 24

treatment of familial amyloidosis. *Proc (Bayl Univ Med Cent)* Vol 20 No (2): 146-148.

echocardiographic features in cardiac amyloidosis. *Circulation* Vol 63 No (1): 188-

randomized trial of melphalan, prednisone, and colchicine versus colchicine only.

amyloid light-chain AL amyloidosis: a case report and literature review. *Amyloid*

*Circulation* Vol 63 No (6): 1285-1288.

*Intern Med* Vol 166 No (17): 1805-1813.

*Am J Med* Vol 100 No (3): 290-298.

polyneuropathy. *Liver Transpl* Vol 9 No (12): 1273-1280.

No (8): 853-855.

196.

No.
